Journal metric profile

Transplantation and Cellular Therapy

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 4.400 2025 metric year
5-Year Impact Factor 4.300 Longer citation window
JCR Quartile Q1 Subject-category quartile
JCR Category Rank Jun-31 Recorded category rank

Transplantation and Cellular Therapy JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Transplantation and Cellular Therapy metric snapshot

Transplantation and Cellular Therapy has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is ELSEVIER SCIENCE INC. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 4.400. The five-year Journal Impact Factor is 4.300, giving a second citation window for comparison. The journal is recorded in quartile Q1 for its listed JCR category.

Category position and quartile

The JCR category rank stored in this record is “Jun-31”. Readers should verify non-standard imported rank formats against the official JCR record. Its listed quartile is Q1. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (4.300) is 0.100 points lower than the standard Journal Impact Factor (4.400). Without journal self-citations, the Impact Factor is 3.800, a difference of 0.600 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 1.110. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Transplantation and Cellular Therapy lists total cites: 4,360; total articles: 249; citable items: 268. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 2.3 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.7 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Transplantation and Cellular Therapy is identified in this directory by print ISSN 2666-6375 and electronic ISSN 2666-6367. The publisher is recorded as ELSEVIER SCIENCE INC. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameTransplantation and Cellular Therapy
Abbreviated journalTRANSPL CELL THER
PublisherELSEVIER SCIENCE INC
Metric year2025
Overall rank2,561
ISSN2666-6375
eISSN2666-6367
Total cites4,360
Total articles249
Citable items268
Cited half-life2.3 years
Citing half-life6.7 years
JCR-based Journal Impact Factor4.400
5-Year Impact Factor4.300
Impact Factor without journal self-cites3.800
Journal Citation Indicator1.110
JCR Impact Factor quartileQ1
JCR category rankJun-31
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Transplantation and Cellular Therapy?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Transplantation and Cellular Therapy is 4.400 for the 2025 metric year.

What are the JCR quartile and category rank of Transplantation and Cellular Therapy?

Transplantation and Cellular Therapy is listed with quartile Q1 and category rank Jun-31. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Transplantation and Cellular Therapy?

The five-year Journal Impact Factor recorded for Transplantation and Cellular Therapy is 4.300. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Transplantation and Cellular Therapy?

Transplantation and Cellular Therapy is listed in this directory as being published by ELSEVIER SCIENCE INC.

Additional records from the same publisher or with a similar listed JCR Impact Factor.